NIH-funded research R01 grant

Understanding the role of gut bacteria in a serious intestinal condition in newborns.

Official title: Dysbiosis in Hirschsprung Associated Enterocolitis Pathogenesis

Funded at University of Virginia · NIH-11239461 · Data updated 2026-11-12

This study is looking into a serious condition called Hirschsprung-associated enterocolitis that affects babies with Hirschsprung Disease, and it aims to find out how certain bad bacteria in the gut might be causing problems, so we can create better treatments that tackle the issue at its source.

More Dysbiosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Virginia
NIH-funded
Lab location1 site (Charlottesville, United States)
Project startApril 1, 2020
Project endJanuary 31, 2026
Funding year2024
Award (this year)$207,778
NIH project number7R01DK125047-06
Project IDNIH-11239461 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are infants diagnosed with Hirschsprung Disease who are at risk of developing Hirschsprung-associated enterocolitis.

Less likely to help

Patients without Hirschsprung Disease or those who do not develop enterocolitis may not benefit from this research.

What this research studies

This research investigates Hirschsprung-associated enterocolitis (HAEC), a severe complication affecting infants with Hirschsprung Disease. The study aims to uncover the underlying mechanisms of HAEC, focusing on how imbalances in gut bacteria may contribute to the condition. By identifying specific harmful bacteria and understanding their interactions with the immune system, the research seeks to develop targeted therapies that go beyond current symptom management. This could lead to improved treatment strategies that address the root causes of HAEC.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that significantly reduce the risk of life-threatening complications in infants with Hirschsprung Disease.

How similar studies have gone: Other research has shown promising results in understanding the role of gut microbiota in various gastrointestinal conditions, suggesting potential for success in this area as well.

Where this research is happening

  • University of Virginia
    Charlottesville, United States
    Active

Researchers

  • Principal investigator: Gosain, Ankush — University of Virginia
  • Study coordinator: Gosain, Ankush

Related research

Other NIH-funded projects on the same topics.

  • Microbial Dysbiosis and Its Role in Pancreatic Cancer

    A doctor-researcher team at Northwestern University is studying how gut bacteria influence pancreatic cancer and its response to immunotherapy to find new ways to help patients.

    NIH research Northwestern University · Chicago, United States · NIH-11624054

  • From Symbiosis to Dysbiosis: How Resolving Inflammation Could Restore Your Mouth’s Balance

    This grant explores how turning off the harmful inflammation in periodontitis and promoting natural healing could help restore the mouth’s healthy balance.

    NIH research Ada Forsyth Institute, INC. · Somerville, UNITED STATES · NIH-11621747

  • Antibiotics, gut health, and skin reactions in kids

    A small study in children will look at whether antibiotic use and gut bacteria play a role in hives and related symptoms that children sometimes get after antibiotics.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11603169

  • Novel therapeutic to protect the gut after radiation

    A new GI-directed treatment given after radiation exposure may reduce gut damage and improve survival in people exposed to high-dose radiation.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11572662

  • A new GI-focused treatment to reduce radiation damage after exposure

    A potential GI-targeted therapy given after radiation exposure may help protect the gut and improve survival in people affected by radiation injuries.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11572658

  • How a mouth bacterium might fuel gum disease and heart risk

    A small study will look at how a bacterium in the mouth that makes a reactive chemical (methylglyoxal) could drive gum inflammation and changes in the mouth’s bacteria, possibly linking to heart disease.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11564245

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.